Cargando…
Shikonin reverses pyruvate kinase isoform M2‐mediated propranolol resistance in infantile hemangioma through reactive oxygen species‐induced autophagic dysfunction
Infantile hemangioma (IH) is the most common benign tumor in infancy. Propranolol, a nonselective β‐adrenergic receptor blocker, is now the first‐line therapy for IH. Recently, low sensitivity to propranolol therapy has become one major reason for the failure of IH treatment. However, the exact unde...
Autores principales: | Yang, Enli, Wang, Xuan, Huang, Shengyun, Li, Mingyang, Li, Yiming, Geng, Yiming, Liu, Xuejian, Chen, Zhanwei, Zhang, Dongsheng, Wu, Haiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986094/ https://www.ncbi.nlm.nih.gov/pubmed/36369903 http://dx.doi.org/10.1111/cas.15649 |
Ejemplares similares
-
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015) -
When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017)